PVP Ventures Ltd

BSE: 517556

total announcements

PVP.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 20 Oct 2026

Market Cap

₹1,187 Cr

P/E (TTM)

227.9

EPS (TTM)

₹0.20

52W Low

₹23.10

52W High

₹72.16

Dividend Yield

0.00%

Beta

0.65

Price / Book

5.4

Debt / Equity

64.7

Revenue (TTM)

₹118 Cr

Gross Margin

75.65%

Operating Margin

15.69%

Announcements Discussion

BSEGeneral▲ PositiveOrder Win10h ago

PVP Ventures Ltd

Signing and Issuance of Letter of Intent to Elekta Solutions AB, Sweden, for the proposed procurement, of ten (10) Harmony, linear accelerator (LINAC) systems, Deal value is expected to be between 11 to 15 million dollars USD.

PVP Ventures Ltd (now Evervie Health Ltd) has signed a Letter of Intent with Elekta Solutions AB, Sweden, for the proposed procurement of ten HARMONY linear accelerator (LINAC) systems. The deal value is expected to be between 11 to 15 million dollars USD. The company has also launched its new official website.

Read more →📎 1 attachment

BSECompany UpdateRegulatory5d ago

PVP Ventures Ltd

Pursuant to Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018 we hereby submit the Reconciliation of share capital Audit report of the company for the quarter ended September 30, 2026, issued by ARS & Associates Company Secretaries LLP, Practising Company Secretaries, and signed by CS K.V.S Subramanyam, Designated Partner.

PVP Ventures Ltd submitted the Reconciliation of Share Capital Audit report for the quarter ended September 30, 2026, as per Regulation 76 of the SEBI (Depositories and Participants) Regulations, 2018.

Read more →📎 1 attachment

BSECompany Update13 Oct 2026

PVP Ventures Ltd

Reporting as per Paragraph 9.1 (a) of the aforesaid Chapter VIII of SEBI Master Circular No. SEBI/HO/DDHS/DDHS -PoD/P/CIR/2025/0000000137 dated October 15, 2025

PVP Ventures Ltd has been renamed to Evervie Health Limited and has submitted details of its non-convertible debentures as per SEBI Master Circular No. SEBI/HO/DDHS/DDHS-PoD/P/CIR/2025/0000000137 dated October 15, 2025.

Read more →📎 1 attachment

BSECompany Update9 Oct 2026

PVP Ventures Ltd

Certificate under Reg 74(5) of SEBI(DP) Regulations,2018 for the Quarter ended 30th September, 2026

PVP Ventures Ltd, now known as Evervie Health Limited, has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30 September 2026.

Read more →📎 1 attachment

BSECompany UpdateDebt Restruc.8 Oct 2026

PVP Ventures Ltd

Regulation 57 of the SEBI (LODR) Regulations, 2015 Company hereby confirms that the interest payable on its Non Convertible Debentures for the scheduled payment dates 31st December, 2026 and 31st March 2027 are paid in advance on 08th October, 2026

PVP Ventures Ltd, now known as Evervie Health Ltd, has paid interest in advance on its Non-Convertible Debentures for the scheduled payment dates of 31st December 2026 and 31st March 2027, amounting to Rs. 13.46 Crores.

Read more →📎 1 attachment

BSEGeneralResults6 Oct 2026

PVP Ventures Ltd

Submission of Updated Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2

PVP Ventures Ltd submitted its updated Annual Report for the Financial Year 2025-26, incorporating necessary changes and corrections, to the BSE and NSE as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment

BSECompany Updatename_change5 Oct 2026

PVP Ventures Ltd

Pursuant to Regulation 30, Regulation 51 and other applicable provisions of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015, we wish to inform you that the Registrar of Companies, Central Processing Centre, Ministry of Corporate Affairs has approved the change of name of the company from "PVP Ventures Limited" to "Evervie Health Limited"

PVP Ventures Ltd has informed the exchanges that the Registrar of Companies has approved the change of name of the company from 'PVP Ventures Limited' to 'Evervie Health Limited'. The change of name is effective from 5th October, 2026.

Read more →📎 1 attachment

BSECompany UpdateDebt Restruc.5 Oct 2026

PVP Ventures Ltd

Pursuant to Regulation 57 of the SEBI ( Listing Obligations and Disclosure requirements) Regulations, 2015, we hereby confirm that the company has made the payment towards the Interest payment in respect of the Non-Convertible Debentures issued by the company.

PVP Ventures Ltd has made the payment towards the Interest payment in respect of the Non-Convertible Debentures issued by the company, as per Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change1 Oct 2026

PVP Ventures Ltd

Pursuant to regulation 30 read with clause 7C Para A of Schedule III of SEBI (LODR) Regulations 2015, the respective communications received from the Dr. Ellen Jane Feehan and Dr. Neeraja Nagarajan Directors, setting out the detailed reasons for their cessation / resignation are enclosed and form an integral part of this disclosure.

PVP Ventures Ltd announces the resignation of Dr. Ellen Jane Feehan and Dr. Neeraja Nagarajan, citing personal and health reasons and non-alignment with the new CEO respectively.

Read more →📎 1 attachment

BSEInsider Trading / SASTResults29 Sept 2026

PVP Ventures Ltd

Trading window for the dealing in securities for all the designated Persons and their immediate relatives and insiders will remain close w.e.f 01.10.2026 till 48 hours after declaration of unaudited financial statements for quarter and half yearly ended on 30th September, 2026

PVP Ventures Ltd has closed its trading window for designated persons, their immediate relatives, and insiders from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.

Read more →📎 1 attachment